Ultrasis Interactive Healthcare fka LSE:ULT

[woolworth]

November 2010 Vol. 11 No. 5 Overview of current work programme

Guidelines
The new guidelines for the management of stroke have been submitted to the Ministry of Health and will be available shortly.

Consultation on the new ‘New Zealand bowel cancer guideline’ has been completed and the results are being assessed. The guideline continues to track well for full delivery (including summaries) in early 2011.

RapidE
“RapidE” is a new product under development by NZGG and being piloted through three projects. The product takes implementation as its starting point, focusing people on what are the 2 to 3 aspects of clinical practice or service delivery that need to change to be aligned with the evidence on best practice. It combines clinical evidence with implementation evidence and aims to deliver implementable tools faster than happens when traditional guidelines are developed.

The RapidE methodology is being deployed in the areas of type 2 diabetes (halfway through the project), rheumatic fever (start of the project) and chronic care self-management (start of the project).

If you want to know more about RapidE, please contact NZGG at 04 471 4180

Other Research Activity
NZGG has held its second substantive meeting of the Living Guideline Group that is overseeing the currency of the New Zealand Autism Spectrum Disorder Guideline. This meeting has considered the evidence supporting the effectiveness of three medications. Recommendations that will supplement the guideline have been developed and NZGG will now draft the second supplementary paper for the guideline.

NZGG has recently completed research in support of guidance that will come out from the Ministry of Health on the promotion of physical activity to older people. NZGG has worked in collaboration with the University of Western Sydney on this project.

As reported in the last Bulletin, NZGG has been trialling an approach to working with sister organisations in the UK. Researchers have completed systematic reviews for guideline work in peripheral arterial disease and hypertension. The project gave NZGG research staff the opportunity to apply the GRADE methodology. The success of the collaboration will be reviewed later in November.

Other Implementation Activity
NZGG has administered a process for establishing a new group to provide advice on autism matters to government departments. The first meeting will be on 1 December.

CCBT Computor Cognitive Behaviour Therapy Ultrasis Beating The blues:-
NZGG is part of a consortium that is implementing an aspect of the 2007 guidelines on the identification of common mental disorders and the management of depression in primary care: electronic cognitive-based therapy. The consortium is led in New Zealand by MedTech Global Ltd and from the UK by Ultrasis Plc. We are implementing Ultrasis’s product, called Beating the Blues for primary care providers across New Zealand from early next year. NZGG’s role is in the training and the adaptation of the Ultrasis website for New Zealand’s context. We also have a responsibility to ensure that the evidence behind the tool is understood by health practitioners.

http://www.nzgg.org.nz/newsletter/dsp_section_template.cfm?BulletinCatID=1&BulletinID=54.0000